Antonio Giordano, MD, PhD. explains what COVID is and how to contain the infection, pointing also to what will require attention next. Please see this special release at http://online.fliphtml5.com/qlnw/zgau/#p=1
The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments. Therapeutic targeting of CCSCs has the potential to reduce resistance to conventional therapies but also limit the occurrence of distant metastasis and relapse. Precision medicine … Continue reading Targeting Cervical Cancer Stem Cells to Improve Outcomes
Weak social groups are diagnosed with more cancers of the digestive system, whereas colorectal cases are more often found in the upper-middle-income social classes. How much does social inequality still affect the evolution of a disease? Evaluating the extent of this impact on the health system would provide us with a complete picture of the … Continue reading “Healthcare: Social Inequalities affect care and mortality.” ~ by Dr. Antonio Giordano
Happy World Health Day 2022 ~ Dr. Antonio Giordano 7th April 2022 is World Health Day! As our society continues to emerge with momentum after the pandemic and the fear of COVID-19 that still persists today; the old challenges such as climate change, pollution, and diseases like cancer, heart diseases, and asthma still haunt humanity. … Continue reading World Health Day 2022!
Dr. Antonio Giordano with Professors and Researchers at Sbarro Institute (SHRO) at Temple University, Philadelphia In the United States, 30th March is celebrated as National Doctor's Day. In historical terms, on 30th March 1933 wife of Dr. Charles B. Almond, Eudora Brown Almond, set aside a date to honor the contributions of physicians; on that … Continue reading National Doctor’s Day, 30th March 2022 – Dr. Antonio Giordano (SHRO)
Dr. Antonio Giordano, Founder & Director of Sbarro Health Research Organization (SHRO) at Temple University's College of Science and Technology, leads a team of researchers and scientists to investigate methods to identify different varieties of cancers at the early stage. Although most people are scared of the word ‘Cancer’ in diseases, as it is well … Continue reading ‘Early Detection of Cancer’ hope for the underprivileged – Dr. Antonio Giordano
An Interview With Savio P. Clemente Cancer is a treatable disease if caught early. For example, most ovarian cancers are detected at late stage (Stage III or higher) and by this time, the cancer is less sensitive to many of the therapies we have available for this disease. The same for breast cancer. Much work … Continue reading Dr Antonio Giordano of Sbarro Health Research Organization: 5 Things Everyone Needs To Know About Cancer
According to recent studies, all those recovered showed up to 9 months later a significant reduction in the ability to apply themselves to a challenging task. Post Covid Effects: Analysis by Dr. Antonio Giordano, Founder & Director of Sbarro Health Research Organization (SHRO) based on recent research studies by several institutions. Sars-Cov2, despite being a … Continue reading Post-Covid Effects: The Invisible Enemy of Memory and Cognitive Skills
Scientists are examining a new coexistence with the virus: isolation of only positives and changes to quarantines limited to close positive contacts 'Omicron and how it's managed at present' a viewpoint shared by Dr. Antonio Giordano, Founder & Director of Sbarro Health Research Organization (SHRO) http://www.shro.org The Omicron variant with its high transmissibility rates is … Continue reading “Omicron: Be Alarmed, not panic! Here is the new management of the pandemic” – Dr. Antonio Giordano
There is no doubt that the use of recently approved drugs to “boost” the immune response to cancer cells represents a novelty that has enriched the arsenal of ammunition against human cancer Nevertheless, even though some of these drugs (i.e. the class of drugs named Immune-checkpoint-Inhibitors, ICi) have been sometimes hailed as “wonder drugs,” the … Continue reading Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow
International Replica project network validated the conclusion of the most important studies on e-cigs. It also confirmed the lower toxicity of aerosol produced by electronic cigarettes in comparison to conventional ones. Thousands of studies with different and often inconsistent results have so far been the primary snag to evaluate the toxicity of e-cigarettes. An issue … Continue reading No more doubts: e-cigs are less toxic than traditional cigarettes.